These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 29210644)
1. Carboxylesterase Inhibitors: An Update. Zou LW; Jin Q; Wang DD; Qian QK; Hao DC; Ge GB; Yang L Curr Med Chem; 2018; 25(14):1627-1649. PubMed ID: 29210644 [TBL] [Abstract][Full Text] [Related]
2. Recent progress in the discovery of natural inhibitors against human carboxylesterases. Wang DD; Zou LW; Jin Q; Hou J; Ge GB; Yang L Fitoterapia; 2017 Mar; 117():84-95. PubMed ID: 28126414 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the inhibition of human carboxylesterases (CESs) by the active ingredients from Fu Q; Yang K; Hu RX; Du Z; Hu CM; Zhang X Xenobiotica; 2019 Nov; 49(11):1260-1268. PubMed ID: 30486721 [TBL] [Abstract][Full Text] [Related]
4. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung. Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485 [TBL] [Abstract][Full Text] [Related]
5. Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase. Shimizu M; Fukami T; Nakajima M; Yokoi T Drug Metab Dispos; 2014 Jul; 42(7):1103-9. PubMed ID: 24751575 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids. Crow JA; Herring KL; Xie S; Borazjani A; Potter PM; Ross MK Biochim Biophys Acta; 2010 Jan; 1801(1):31-41. PubMed ID: 19761868 [TBL] [Abstract][Full Text] [Related]
7. Human carboxylesterases: a comprehensive review. Wang D; Zou L; Jin Q; Hou J; Ge G; Yang L Acta Pharm Sin B; 2018 Sep; 8(5):699-712. PubMed ID: 30245959 [TBL] [Abstract][Full Text] [Related]
8. Effects of alcohol on human carboxylesterase drug metabolism. Parker RB; Hu ZY; Meibohm B; Laizure SC Clin Pharmacokinet; 2015 Jun; 54(6):627-38. PubMed ID: 25511794 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon. Crow JA; Bittles V; Herring KL; Borazjani A; Potter PM; Ross MK Toxicol Appl Pharmacol; 2012 Jan; 258(1):145-50. PubMed ID: 22100607 [TBL] [Abstract][Full Text] [Related]
10. Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity. Wong CC; Cheng KW; Xie G; Zhou D; Zhu CH; Constantinides PP; Rigas B J Pharmacol Exp Ther; 2012 Feb; 340(2):422-32. PubMed ID: 22085648 [TBL] [Abstract][Full Text] [Related]
11. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2. Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359 [TBL] [Abstract][Full Text] [Related]
12. Identification of carboxylesterases expressed in rat intestine and effects of their hydrolyzing activity in predicting first-pass metabolism of ester prodrugs. Liu D; Gao J; Zhang C; Ren X; Liu Y; Xu Y Pharmazie; 2011 Nov; 66(11):888-93. PubMed ID: 22204136 [TBL] [Abstract][Full Text] [Related]
13. Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597. Crow JA; Bittles V; Borazjani A; Potter PM; Ross MK Biochem Pharmacol; 2012 Nov; 84(9):1215-22. PubMed ID: 22943979 [TBL] [Abstract][Full Text] [Related]
14. Discovery of natural pentacyclic triterpenoids as potent and selective inhibitors against human carboxylesterase 1. Song PF; Zhu YD; Ma HY; Wang YN; Wang DD; Zou LW; Ge GB; Yang L Fitoterapia; 2019 Sep; 137():104199. PubMed ID: 31175950 [TBL] [Abstract][Full Text] [Related]
15. Discovery of pyrazolones as novel carboxylesterase 2 inhibitors that potently inhibit the adipogenesis in cells. Qian XK; Zhang J; Song PF; Zhao YS; Ma HY; Jin Q; Wang DD; Guan XQ; Li SY; Bao X; Zou LW Bioorg Med Chem; 2021 Jun; 40():116187. PubMed ID: 33965840 [TBL] [Abstract][Full Text] [Related]
16. Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3. Sanghani SP; Quinney SK; Fredenburg TB; Davis WI; Murry DJ; Bosron WF Drug Metab Dispos; 2004 May; 32(5):505-11. PubMed ID: 15100172 [TBL] [Abstract][Full Text] [Related]
17. Potential Pharmacokinetic Herb-Drug Interactions: Have we Overlooked the Importance of Human Carboxylesterases 1 and 2? Xu J; Qiu JC; Ji X; Guo HL; Wang X; Zhang B; Wang T; Chen F Curr Drug Metab; 2019; 20(2):130-137. PubMed ID: 29600756 [TBL] [Abstract][Full Text] [Related]
19. Biotransformation Capacity of Carboxylesterase in Skin and Keratinocytes for the Penta-Ethyl Ester Prodrug of DTPA. Fu J; Sadgrove M; Marson L; Jay M Drug Metab Dispos; 2016 Aug; 44(8):1313-8. PubMed ID: 27130352 [TBL] [Abstract][Full Text] [Related]
20. Per- and polyfluoroalkyl substances exert strong inhibition towards human carboxylesterases. Liu YZ; Pan LH; Bai Y; Yang K; Dong PP; Fang ZZ Environ Pollut; 2020 Aug; 263(Pt A):114463. PubMed ID: 32283456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]